Distinct Origins and Transmission Pathways of blaKPC Enterobacterales across Three U.S. States
- PMID: 37439675
- PMCID: PMC10446861
- DOI: 10.1128/jcm.00259-23
Distinct Origins and Transmission Pathways of blaKPC Enterobacterales across Three U.S. States
Abstract
Carbapenem-resistant Enterobacterales (CRE) are among the most concerning antibiotic resistance threats due to high rates of multidrug resistance, transmissibility in health care settings, and high mortality rates. We evaluated the potential for regional genomic surveillance to track the spread of blaKPC-carrying CRE (KPC-CRE) by using isolate collections from health care facilities in three U.S. states. Clinical isolates were collected from Connecticut (2017 to 2018), Minnesota (2012 to 2018), and Tennessee (2016 to 2017) through the U.S. Centers for Disease Control and Prevention's Multi-site Gram-negative Surveillance Initiative (MuGSI) and additional surveillance. KPC-CRE isolates were whole-genome sequenced, yielding 255 isolates from 214 patients across 96 facilities. Case report data on patient comorbidities, facility exposures, and interfacility patient transfer were extracted. We observed that in Connecticut, most KPC-CRE isolates showed evidence of importation from outside the state, with limited local transmission. In Minnesota, cases were mainly from sporadic importation and transmission of blaKPC-carrying Klebsiella pneumoniae ST258, and clonal expansion of blaKPC-carrying Enterobacter hormaechei ST171, primarily at a single focal facility and its satellite facilities. In Tennessee, we observed transmission of diverse strains of blaKPC-carrying Enterobacter and Klesbiella, with evidence that most derived from the local acquisition of blaKPC plasmids circulating in an interconnected regional health care network. Thus, the underlying processes driving KPC-CRE burden can differ substantially across regions and can be discerned through regional genomic surveillance. This study provides proof of concept that integrating genomic data with information on interfacility patient transfers can provide insights into locations and drivers of regional KPC-CRE burden that can enable targeted interventions.
Keywords: carbapenem-resistant Enterobacterales (CRE); importation; patient transfer; transmission.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Centers for Disease Control and Prevention. 2019. Antibiotic resistance threats in the United States, 2019. https://stacks.cdc.gov/view/cdc/82532. Accessed 11 June 2020.
-
- Lee BY, Bartsch SM, Wong KF, Kim DS, Cao C, Mueller LE, Gussin GM, McKinnell JA, Miller LG, Huang SS. 2019. Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated. Infect Control Hosp Epidemiol 40:731–734. doi: 10.1017/ice.2019.61. - DOI - PMC - PubMed
-
- World Health Organization. 2014. Antimicrobial resistance: global report on surveillance. World Health Organization, Geneva, Switzerland.
-
- Han JH, Lapp Z, Bushman F, Lautenbach E, Goldstein EJC, Mattei L, Hofstaedter CE, Kim D, Nachamkin I, Garrigan C, Jain T, Bilker W, Wolford HM, Slayton RB, Wise J, Tolomeo P, Snitkin ES. 2019. Whole-genome sequencing to identify drivers of carbapenem-resistant Klebsiella pneumoniae transmission within and between regional long-term acute-care hospitals. Antimicrob Agents Chemother 63:e01622-19. doi: 10.1128/AAC.01622-19. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
